Jim Simons
KURA icon

Jim Simons’s Kura Oncology KURA Stock Holding History

Jim Simons’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Sell
1,582,568
-247,998
-14% -$2.13M 0.02% 839
2025
Q4 		$19M Buy
1,830,566
+965,256
+112% +$10.1M 0.03% 626
2025
Q3 		$7.66M Sell
865,310
-191,700
-18% -$1.37M 0.01% 1227
2025
Q2 		$6.1M Buy
1,057,010
+524,400
+98% +$3.21M 0.01% 1389
2025
Q1 		$3.52M Sell
532,610
-65,200
-11% -$508K 0.01% 1647
2024
Q4 		$5.21M Buy
597,810
+491,700
+463% +$7.08M 0.01% 1432
2024
Q3 		$2.07M Sell
106,110
-15,090
-12% -$306K ﹤0.01% 1993
2024
Q2 		$2.5M Sell
121,200
-119,000
-50% -$2.45M ﹤0.01% 1734
2024
Q1 		$5.12M Sell
240,200
-37,900
-14% -$737K 0.01% 1390
2023
Q4 		$4M Buy
278,100
+162,500
+141% +$1.6M 0.01% 1492
2023
Q3 		$1.05M Sell
115,600
-72,500
-39% -$736K ﹤0.01% 2254
2023
Q2 		$1.99M Buy
188,100
+171,500
+1,033% +$2.03M ﹤0.01% 2002
2023
Q1 		$203K Buy
+16,600
New +$207K ﹤0.01% 3272
2022
Q4 		– Sell
-124,500
Closed -$1.7M – 4267
2022
Q3 		$1.7M Sell
124,500
-20,500
-14% -$316K ﹤0.01% 2123
2022
Q2 		$2.66M Sell
145,000
-133,400
-48% -$1.92M ﹤0.01% 1986
2022
Q1 		$4.48M Buy
278,400
+210,700
+311% +$3.04M 0.01% 1675
2021
Q4 		$948K Sell
67,700
-106,400
-61% -$1.72M ﹤0.01% 2687
2021
Q3 		$3.26M Sell
174,100
-128,100
-42% -$2.41M ﹤0.01% 1722
2021
Q2 		$6.3M Buy
+302,200
New +$7.5M 0.01% 1489
2020
Q2 		– Sell
-85,271
Closed -$848K – 3619
2020
Q1 		$848K Buy
+85,271
New +$976K ﹤0.01% 2507
2018
Q1 		– Sell
-89,294
Closed -$1.37M – 3474
2017
Q4 		$1.37M Sell
89,294
-177,106
-66% -$2.61M ﹤0.01% 2533
2017
Q3 		$3.98M Buy
266,400
+176,400
+196% +$1.66M ﹤0.01% 1906
2017
Q2 		$837K Buy
90,000
+10,800
+14% +$98.3K ﹤0.01% 2627
2017
Q1 		$697K Buy
79,200
+48,600
+159% +$356K ﹤0.01% 2666
2016
Q4 		$181K Buy
30,600
+6,200
+25% +$33.2K ﹤0.01% 3021
2016
Q3 		$153K Buy
24,400
+11,100
+83% +$56.2K ﹤0.01% 3115
2016
Q2 		$36K Buy
+13,300
New +$41.4K ﹤0.01% 3256

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jim Simons's KURA Position: Q1 2026 in Review

Jim Simons reduced its Kura Oncology (KURA) stake by 14% in Q1 2026, selling an estimated $2.13M and leaving 1,582,568 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #839.

Jim Simons first reported a position in KURA in Q2 2016 and has held it in 27 quarters since. The position peaked at $19M in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Jim Simons held 1,582,568 shares of Kura Oncology worth $12.9M as of Q1 2026.
  • Jim Simons sold 247,998 Kura Oncology shares in Q1 2026, an estimated $2.13M.
  • Kura Oncology made up 0.02% of Jim Simons's portfolio in Q1 2026, its #839 holding.
  • Jim Simons first reported a position in Kura Oncology in Q2 2016 and has held it in 27 quarters since.
  • Jim Simons's Kura Oncology position peaked at $19M in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.